• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Balchem Corporation

    6/24/25 4:38:30 PM ET
    $BCPC
    Major Chemicals
    Industrials
    Get the next $BCPC alert in real time by email
    11-K 1 bcpc-20241231x11k.htm 11-K Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 11-K



    [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended: December 31, 2024

    OR

    [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For transition period from __________ to ___________

    Commission file number 1-13648

    A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

    Balchem Corporation 401(k) Plan

    B. Name of the issuer of the securities held pursuant to the plan and the address of its principal executive office:


    Balchem Corporation
    5 Paragon Drive
    Montvale, NJ 07645





    Table of Contents
    REQUIRED INFORMATION

    The following financial statements shall be furnished for the plan:
    4.
    In lieu of requirements of Items 1-3, the Balchem Corporation 401(k) Plan (“the Plan”) is subject to the requirements of the Employee Retirement Insurance Security Act of 1974, as amended (“ERISA”). Attached hereto are the financial statements of the Balchem Corporation 401(k) Plan for the fiscal year ended December 31, 2024, prepared in accordance with the financial reporting requirements of ERISA.

    EXHIBITS
    1.
    Financial Statements of the Balchem Corporation 401(k) Plan for the fiscal year ended December 31, 2024, prepared in accordance with the financial reporting requirements of ERISA.
    23.1Consent of BDO USA, P.C., Independent Registered Public Accounting Firm.
    23.2Consent of RSM US LLP, Independent Registered Public Accounting Firm.


    EXHIBIT INDEX
    Exhibit No. Exhibit Description
    1
    Financial Statements of the Balchem Corporation 401(k) Plan for the fiscal year ended December 31, 2024, prepared in accordance with the financial reporting requirements of ERISA.
    23.1
    Consent of BDO USA, P.C.
    23.2
    Consent of RSM US LLP




    Table of Contents
    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date:
    June 24, 2025
    BALCHEM CORPORATION
    401(k) PLAN
    By: Balchem Corporation,
                Plan Administrator
    By: /s/ Theodore L. Harris
    Theodore L. Harris, Chairman, President and
    Chief Executive Officer
    By: /s/ Martin Bengtsson
    Martin Bengtsson, Executive Vice President and
    Chief Financial Officer



    Table of Contents

    BALCHEM CORPORATION
    401(k) PLAN

    Financial Statements
    and Supplemental Schedules

    December 31, 2024 and 2023

    (With Reports of Independent Registered Public Accounting Firms)



    Table of Contents
    BALCHEM CORPORATION
    401(k) PLAN

    TABLE OF CONTENTS
    Page No.
    Report of Independent Registered Public Accounting Firm - BDO USA, P.C.
    1
    Report of Independent Registered Public Accounting Firm - RSM US LLP
    2
    Statements of Net Assets Available for Benefits
    3
    Statement of Changes in Net Assets Available for Benefits
    4
    Notes to Financial Statements
    5
    Supplemental Information
    Schedule H, Line 4(i) - Schedule of Assets (Held at End of Year)
    11


    Table of Contents
    Report of Independent Registered Public Accounting Firm

    Plan Administrator and Participants
    Balchem Corporation 401(k) Plan
    Middletown, New York

    Opinion on the Financial Statements

    We have audited the accompanying statement of net assets available for benefits of the Balchem Corporation 401(k) Plan (the “Plan”) as of December 31, 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2024, and the related notes (collectively, the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2024, and the changes in net assets available for benefits for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

    Basis for Opinion

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

    Our audit included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by the Plan’s management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

    Supplemental Information

    The supplemental information in the accompanying Schedule H, line 4i – Schedule of Assets (Held at End of Year) as of December 31, 2024 has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is presented for the purpose of additional analysis and is not a required part of the financial statements but included supplemental information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.
     
    /s/ BDO USA, P.C.

    We have served as the Plan’s auditor since 2025.

    New York, New York

    June 24, 2025
    1

    Table of Contents


    Report of Independent Registered Public Accounting Firm

    To the Trustees, Plan Administrator, and Plan Participants of Balchem Corporation 401(k) Plan

    Opinion on the Financial Statement

    We have audited the accompanying statement of net assets available for benefits of Balchem Corporation 401(k) Plan (the Plan) as of December 31, 2023, and the related notes (the financial statement). In our opinion, the financial statement presents fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

    Basis for Opinion

    This financial statement is the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statement based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statement is free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statement, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statement. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statement. We believe that our audit provides a reasonable basis for our opinion.

     
    /s/ RSM US LLP

    We have served as the Plan’s auditor from 2004 to 2024.

    Dallas, Texas

    June 18, 2024
    2

    Table of Contents
    BALCHEM CORPORATION
    401(k) PLAN
    Statements of Net Assets Available for Benefits
    December 31, 2024 and 2023
     20242023
    Assets:
    Investments at fair value (Note 4)$119,174,938 $108,629,789 
    Investments at contract value (Note 3)20,760,598 21,668,056 
    Receivables:
    Employer contribution131,922 — 
    Promissory notes receivable from participants1,706,222 1,722,033 
    Net assets available for benefits$141,773,680 $132,019,878 
    See Notes to Financial Statements

    3

    Table of Contents
    BALCHEM CORPORATION
    401(k) PLAN
    Statement of Changes in Net Assets Available for Benefits
    Year Ended December 31, 2024
    2024
    Additions to net assets attributed to:
    Investment income:
    Net appreciation in fair value of investments$9,683,360 
    Interest, dividend, and other investment income4,126,126 
    Total13,809,486 
    Interest income - promissory notes receivable from participants143,572 
    Contributions:
    Participant contributions6,306,647 
    Rollover contributions1,223,453 
    Employer contributions4,776,030 
    Total12,306,130 
    Total additions26,259,188 
    Deductions from net assets attributed to:
    Benefits paid to participants(16,326,431)
    Fees, net(178,955)
    Total(16,505,386)
    Total deductions(16,505,386)
    Net increase in net assets available for benefits9,753,802 
    Net Assets available at beginning of the year132,019,878 
    Net Assets available at end of year$141,773,680 
    See Notes to Financial Statements

    4

    Table of Contents
    BALCHEM CORPORATION
    401(k) PLAN
    Notes to Financial Statements
    December 31, 2024 and 2023


    NOTE 1 - DESCRIPTION OF THE PLAN
    The following description of the Balchem Corporation 401(k) (the “Plan”) provides only general information. Participants should refer to the Plan agreement for a complete description of the Plan’s provisions.

    General

    The Plan is principally a participant directed, defined contribution plan, and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).

    Empower Annuity Insurance Company ("Empower") is the Plan's administrative services provider and record keeper. The Plan's previous administrative service provider and record keeper was Prudential Retirement Insurance and Annuity Company, which was acquired by Empower on April 4, 2022.

    The 401(k) and Safe Harbor Matching portion of the Plan covers all active U.S. employees of Balchem Corporation (the “Company”, or "Employer") who have completed two months of service, as defined, and are 18 years of age or older, except those who are currently covered by a collective bargaining agreement. Employees are automatically enrolled in the Plan on the first day of the month after they become eligible to participate and can elect to opt-out at any time.

    The Company's non-elective profit sharing contribution portion of the Plan covers all active U.S. employees who have completed 1,000 hours of service, as defined, are 18 years of age or older, and are active employees of the Company at December 31.

    Administrative Expenses

    The Company pays administrative and record keeping fees for the Plan. Plan participants are required to pay fees for participant loans and certain brokerage fees for transactions pertaining to investments in Balchem Corporation common stock.

    Contributions

    Participants are allowed to contribute annually, in pre-tax or after tax dollars, a percentage of compensation as defined by the Plan, up to the maximum of the lesser of 75% of their eligible compensation or the annual limit allowed by the Internal Revenue Code (“IRC”) ($23,000 in 2024 and $22,500 in 2023). Participants 50 years and older may opt to contribute additional catch-up contributions up to $7,500 for the years ended December 31, 2024 and 2023, respectively. Participants may also contribute amounts representing distributions from other qualified defined benefit or defined contribution plans. For the year ended December 31, 2024, $1,223,453 of rollover contributions were included in participant contributions. Participants direct the investment of their contributions into various investment options offered by the Plan. To maintain “safe harbor” status, the employer will make a safe harbor matching contribution equal to 100% of the elective deferrals that do not exceed 6% of compensation. The safe harbor matching contribution is 100% vested. Employer safe harbor matching contributions are made in cash, which is then used to purchase Balchem Corporation common stock. Non-elective employer profit sharing contributions are subject to the vesting schedules described below. The employer contribution receivable of $131,922 as of December 31, 2024 was a true up of the Company's safe harbor matching contribution.

    Participant Accounts

    Each participant’s account is credited with the participant’s contribution and allocations of the Company’s matching contributions and plan earnings or losses. Allocations are based on participant account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s vested account.

    5

    Table of Contents
    Vesting

    Participants are 100% vested in their contributions (including rollovers) and employer safe harbor contributions, plus actual earnings or losses thereon. Vesting in the non-elective employer profit sharing contribution portion of their accounts plus actual earnings or losses thereon is based on years of continuous service, as defined. The vesting timeline is as follows:

    Years of Vesting ServiceVesting Percentage
    Less than One Year0%
    One Year but less than Two Years20%
    Two Years but less than Three Years40%
    Over Three Years100%

    For employees hired as part of certain acquisitions, their prior credited service is used in determining the vested portion of such matching contributions. There was no non-elective profit sharing contribution for the year ended December 31, 2024. Participants become fully vested in the event of death and disability, as defined by the Plan.

    Investment Options

    Upon enrollment in the Plan, participants may direct employee contributions to the various investment options administered by Empower and a maximum of 10% of a participant’s contribution to Balchem Corporation Common Stock Fund. Employer matching contributions are made in cash which is then used to purchase Balchem Corporation common stock. Participants are able to transfer funds out of the Company stock fund to other investments offered by the Plan at any time. Non-elective employer profit sharing contributions are made from the Company’s cash reserves.

    Promissory Notes Receivable from Participants

    Promissory notes receivable from participants represent loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Participants may borrow from their fund accounts a minimum of $1,000 up to a maximum equal to the lesser of $50,000 or 50% of their vested account balances. Loan terms extend up to five years or between five and ten years for the purchase of a primary residence. The loans are secured by the balance in the participants’ accounts and bear interest at a fixed rate based on the prime rate plus 2% at the time of loan origination and range from 4.50% to 10.50% at December 31, 2024 and 2023. Principal and interest are paid ratably through payroll deductions. No allowance for credit losses has been recorded at December 31, 2024 or 2023. In the event of default, such loans are reportable to Plan participants as taxable income but remain outstanding and continue to accrue interest until repaid by the Plan participant or the participant becomes eligible to receive a distribution under the terms of the Plan.

    Payment of Benefits

    On termination of service, a participant may receive a lump sum amount equal to the vested value of his or her account, or upon death, disability or retirement, the participant may elect to receive annual installments over a period not to exceed the participant’s lifetime, or the joint lifetime of the participant and the participant’s spouse. Immediate lump sum distributions occur when a vested account balance is $5,000 or less. When a vested account balance is between $1,000 and $5,000, it is automatically rolled into an individual retirement account ("IRA"). Participants may also withdraw an amount at age 59 1/2 if certain criteria are met.

    Income (Loss) Allocations

    Investment income (loss) for an accounting period shall be allocated to participants’ accounts in proportion to the total of their respective account balances at the beginning of such accounting period plus any contributions or loan repayments credited to the account, less any loans issued or other deductions during the period.

    Forfeited Accounts

    Forfeited balances of terminated participants’ non-vested accounts may be used to reduce the Company safe harbor matching contributions, to reduce non-elective profit sharing contributions, or to pay the Plan expenses. Forfeited non-vested accounts at
    6

    Table of Contents
    December 31, 2024 and 2023 totaled $60,391 and $42,467, respectively. During the year ended December 31, 2024, forfeitures of $2,105 were used to pay the Plan expenses.

    Risks and Uncertainties

    The assets of the Plan at December 31, 2024 and 2023 are primarily financial instruments that are monetary in nature. The Plan invests in funds managed by third-parties, Balchem Corporation common stock, and an investment contract. These investments are subject to risk conditions of the individual investments’ objectives, the stock market, interest rates, economic conditions, world affairs and, in the case of the Balchem Corporation common stock, the results of operations and other risks specific to Balchem Corporation. Due to the level of risk associated with certain investment changes in the value of investment securities, it is at least reasonably possible that changes in the values of investments will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Plan Benefits and the Statement of Changes in Net Assets Available for Plan Benefits.


    NOTE 2 - SUMMARY OF ACCOUNTING POLICIES

    Basis of Accounting

    The financial statements of the Plan are presented on the accrual basis of accounting.

    Investment Valuation and Income Recognition

    The Plan’s investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GIF is stated at contract value. Common stock and Registered Investment Companies are valued based upon quoted market prices.

    Purchases and sales of securities are recorded on a trade date basis. Interest income is recorded on an accrual basis. Dividends are recorded on the ex-dividend date. Net appreciation in the fair value of investments includes the Plan's gains and losses on investments bought and sold as well as held during the year.

    Contributions:

    Participant contributions and any related employer matching contributions are recognized in the period during which the employer makes the respective payroll deduction from the participant's compensation.

    Payment of Benefits

    Benefits are recorded when paid.

    Expenses

    Investment-related expenses are included within net appreciation in fair value of investments from Empower on the Statement of Changes in Net Assets Available for Benefits. Administrative expenses and record keeping fees for the Plan are included within "Fees, net" on the Statement of Changes in Net Assets Available for Benefits. In addition, fees related to the administration of participant loans are charged directly to the participant's account and are also included within "Fees, net" on the Statement of Changes in Net Assets Available for Benefits.

    Use of Estimates

    The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Plan Administrator to make estimates and assumptions that could affect the reported amounts of net assets at the date of the financial statements and the reported amounts of changes in net assets available for benefits and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates.


    7

    Table of Contents

    NOTE 3 - Investment Contract

    The Guaranteed Income Fund ("GIF") is recorded at contract value and invests in a broadly diversified, fixed-income portfolio that is primarily invested in public bonds, commercial mortgages, and private placement bonds. GIF provides a specified rate of return for a specified period of time. Contract value represents contributions and reinvested income, less any withdrawals plus accrued interest, because these investments have fully benefit-responsive features. For example, participants may ordinarily direct the withdrawal or transfer of all or a portion of their investment at contract value. There are no reserves against contract values for credit risk of contract issues or otherwise. There are no events that limit the ability of the Plan to transact at contract value with Empower. GIF does not have a maturity date and there are no instances that allow Empower to terminate the agreement (contract). The contract value of GIF was $20,760,598 and $21,668,056 as of December 31, 2024 and 2023, respectively.


    NOTE 4 - FAIR VALUE MEASUREMENTS

    Fair Value Measurements
    The Plan accounts for its investments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC 820 are described below:
    Level 1 Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.
    Level 2 Inputs to the valuation methodology include:
    - Quoted prices for similar assets or liabilities in active markets;
    - Quoted prices for identical or similar assets or liabilities in inactive markets;
    - Inputs other than quoted prices that are observable for the asset or liability;
    - Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
    If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.
    Level 3 Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

    Market data or assumptions about risk and the risks inherent in the inputs are used in the valuation technique. These inputs can be readily observable, market corroborated or generally observable. Primarily the market approach for recurring fair value measurements is applied and also endeavors to utilize the best available information. Accordingly, the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs are utilized. Fair value balances have been classified based on the observance of those inputs into the fair value hierarchy levels as set forth in the fair value accounting guidance.

    The following is a description of the valuation methodologies used for the investments measured at fair value, including the general classification of such instruments pursuant to the valuation hierarchy:

    •Balchem Corporation Common Stock: Valued at the closing price as quoted on the Nasdaq Stock Market LLC and is classified as a Level 1 investment.

    •Registered Investment Companies: Valued at the quoted closing market price and are classified as Level 1 investments.

    The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

    There have been no changes in the methodologies used at December 31, 2024 and 2023.
    8

    Table of Contents

    The following tables set forth by level, within the fair value hierarchy, the Plan’s assets at fair value as of December 31, 2024 and 2023:

    Assets at Fair Value as of December 31, 2024
    Quoted Prices In Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
    (Level 2)
    Significant Unobservable Inputs
    (Level 3)
    Total
    Common Stock of Balchem Corporation$38,437,832 $— $— $38,437,832 
    Registered Investment Companies80,737,106 — — 80,737,106 
    Total Investments$119,174,938 $— $— $119,174,938 

    Assets at Fair Value as of December 31, 2023
    Quoted Prices In Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
    (Level 2)
    Significant Unobservable Inputs
    (Level 3)
    Total
    Common Stock of Balchem Corporation$34,797,937 $— $— $34,797,937 
    Registered Investment Companies73,831,852 — — 73,831,852 
    Total Investments$108,629,789 $— $— $108,629,789 

    NOTE 5 - PARTIES-IN-INTEREST
    As of December 31, 2024 and 2023, the Plan held 235,822 and 233,936 shares of Balchem Corporation common stock, respectively, with a market value of $38,437,832 and $34,797,937 at December 31, 2024 and 2023, respectively. Certain Plan investments are shares of various funds managed by Empower. Empower is the trustee of the Plan and, therefore, these transactions are considered party-in-interest transactions, which are exempt from prohibited transaction rules. Promissory Notes Receivable from Participants are also considered to be party-in-interest transactions, which are exempt from prohibited transaction rules.

    NOTE 6 - PLAN TERMINATION
    Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of Plan termination, participants will become 100% vested in their accounts.

    NOTE 7 - INCOME TAX STATUS
    The Plan has received a favorable determination letter dated September 16, 2022 from the Internal Revenue Service ruling that it is a qualified plan pursuant to the appropriate section of the IRC and, accordingly, the earnings of the underlying trust of the Plan are not subject to tax under present income tax law. Once qualified, the Plan is required to operate in conformity with the IRC to maintain its qualifications. Although the Plan has been amended since receiving the determination letter, the Plan Administrator and the Plan’s tax counsel believe that the Plan is designed and is currently being operated in compliance with the applicable requirements of the IRC.

    The Plan accounts for uncertainty in income taxes utilizing ASC 740-10. Management evaluated the Plan’s tax positions and concluded that the Plan had maintained its tax exempt status and had taken no uncertain tax positions that require adjustment to the financial statements. Therefore, no provision or liability for income taxes has been included in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no IRS examinations for any tax periods in progress.

    9

    Table of Contents
    The Plan was informed that the Department of Labor is conducting an inquiry beginning with Plan year ended December 31, 2019. The investigation is in progress.

    NOTE 8 - SUBSEQUENT EVENTS

    The Plan has evaluated subsequent events through June 24, 2025, the date the financial statements were available to be issued, and has determined that no significant events occurred after December 31, 2024, but prior to the issuance of these financial statements, that would have a material impact on its financial statements.



    10

    Table of Contents
    EIN: 13-2578432
    Plan number: 005
    BALCHEM CORPORATION
    401(k) PLAN
    Supplemental Information
    December 31, 2024

    Schedule H, Line 4(i) - Schedule of Assets
    Held at End of Year
    (a)(b) Identity of issue, borrower, lessor or similar party(c) Description of investments including maturity date, rate of interest, collateral, par or maturity value
    (d) Cost (2)
    (e) Current value
    (1)
    Empower Annuity Insurance CompanyGuaranteed Income Fund$20,760,598 
    (1)
    Balchem Corporation Balchem Corporation Common Stock38,437,832 
    Fidelity InvestmentsFidelity Total Market Index Fund15,423,080 
    American FundsAmerican Funds American Balanced Fund Class R-68,944,170 
    American Century InvestmentsAmerican Century Growth Fund R6 Class8,858,923 
    Victory CapitalVictory Pioneer Bond Fund R67,560,635 
    Columbia ThreadneedleColumbia Dividend Income Fund Institutional 3 Class7,225,363 
    American FundsAmerican Funds EUPAC Fund Class R-66,684,732 
    Fidelity InvestmentsFidelity Total International Index Fund6,141,697 
    Fidelity InvestmentsFidelity Small Cap Index Fund6,043,434 
    Fidelity InvestmentsFidelity U.S. Bond Index Fund5,555,717 
    Fidelity InvestmentsFidelity Mid Cap Index Fund4,395,830 
    Carillon Family of FundsCarillon Eagle Mid Cap Growth Fund Class R63,903,525 
    (1)
    Participant Loans Interest rates range from 4.50% to 10.50% — 1,706,222 
    Total$141,641,758 

    (1) Parties-in-interest
    (2) All investments held are participant directed.
    11
    Get the next $BCPC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BCPC

    DatePrice TargetRatingAnalyst
    3/8/2022$170.00 → $155.00Buy
    HC Wainwright & Co.
    2/22/2022$175.00Neutral → Buy
    Sidoti
    1/10/2022$160.00 → $170.00Buy
    HC Wainwright & Co.
    11/29/2021$175.00Buy → Neutral
    Sidoti
    8/2/2021$140.00 → $145.00Overweight → Equal-Weight
    Stephens & Co.
    8/2/2021$145.00 → $160.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BCPC
    SEC Filings

    See more
    • SEC Form 11-K filed by Balchem Corporation

      11-K - BALCHEM CORP (0000009326) (Filer)

      6/24/25 4:38:30 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - BALCHEM CORP (0000009326) (Filer)

      6/20/25 4:16:23 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Balchem Corporation

      SCHEDULE 13G/A - BALCHEM CORP (0000009326) (Subject)

      5/14/25 4:34:20 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025

      MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Thursday, July 31, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. To improve the quality of both the live and recorded audio for our conference calls, we have ch

      7/17/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025

      MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Annual New Ideas Summer Conference on July 10, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest qual

      6/26/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025

      MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the fi

      5/28/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 2,128 shares and covered exercise/tax liability with 964 shares, increasing direct ownership by 14% to 9,446 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 7:11:10 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP & Chief HR Officer Tignor Michael Brent was granted 3,497 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 35% to 9,123 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:43:35 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:38:36 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $155.00 from $170.00 previously

      3/8/22 6:19:56 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem upgraded by Sidoti with a new price target

      Sidoti upgraded Balchem from Neutral to Buy and set a new price target of $175.00

      2/22/22 8:56:13 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $170.00 from $160.00 previously

      1/10/22 6:15:56 AM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Financials

    Live finance-specific insights

    See more
    • Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025

      MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Thursday, July 31, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. To improve the quality of both the live and recorded audio for our conference calls, we have ch

      7/17/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation Reports First Quarter 2025 Financial Results

      MONTVALE, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2025 fiscal first quarter ended March 31, 2025. For the quarter, the Company reported net sales of $250.5 million, net earnings of $37.1 million, adjusted EBITDA(a) of $66.3 million, and free cash flow(a) of $31.0 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record net sales and adjusted EBITDA, strong net earnings, and solid first quarter cash flows." First Quarter 2025 Financial Highlights: Record net sales o

      4/24/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025

      MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 24, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341),

      4/11/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Leadership Updates

    Live Leadership Updates

    See more
    • AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

      BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ:AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRx's Board to seven members. Ms. Coelho currently serves as the Executive Vice President and Chief Financial Officer at BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a commercial-stage specialty pharmaceutical company. During her more than 30-year career, Ms. Coelho has held numerous senior level financial an

      8/16/21 8:00:00 AM ET
      $AZRX
      $BCPC
      $BDSI
      Major Pharmaceuticals
      Health Care
      Major Chemicals
      Industrials

    $BCPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Balchem Corporation

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      11/13/24 6:56:07 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      2/13/24 4:59:02 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      2/9/24 11:29:17 AM ET
      $BCPC
      Major Chemicals
      Industrials